LOS GATOS, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Atomera Incorporated ATOM, a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2018.
Company Highlights
- Signed integration license agreements with Asahi Kasei Microdevices and STMicroelectronics
- Added two new customers to reach 20 engagements underway with 16 different customers
- Strengthened balance sheet with $11.5 million of net proceeds from equity offering
- Four new patents granted
Management Commentary
"With the first two licenses executed, and a robust balance sheet, Atomera is stronger than ever and well positioned to deliver meaningful shareholder value as we deploy MST into semiconductor foundries and IDMs," said Scott Bibaud, President and CEO. "Further, we continue to augment our intellectual property portfolio with four new US patents allowed during the quarter and improvements to MST that will bring new value to our customers. We achieved these results while holding our cash consumption basically flat compared to Q2."
Third Quarter 2018 Financial Results
During the third quarter of 2018 the Company incurred a net loss of $3.4 million, or ($0.28) per basic and diluted share, compared to a net loss of $3.3 million, or ($0.28) per basic and diluted share, for the third quarter of 2017. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2018 was a loss of $2.8 million compared to an adjusted EBITDA loss of $2.4 million in the third quarter of 2017.
The Company had $10.0 million in cash and cash equivalents as of Sept. 30, 2018, compared to $12.3 million as of June 30, 2018 and $17.4 million as of December 31, 2017. The Company's equity financing closed on October 15, 2018 adding $11.5 million to Atomera's cash balance.
The total number of shares outstanding was 12,408,525 as of Sept. 30, 2018. After completion of the Company's equity offering on October 15, 2018, shares outstanding were 15,033,525.
2018 Third Quarter Results Conference Call and Webcast
Atomera will host a conference call today to discuss its financial results and recent progress.
Date: Thursday, Nov. 1, 2018
Time: 2:00 p.m. PT (5:00 p.m. ET)
Phone: (844) 263-8318 (domestic); +1 (213) 3580960 (international)
Replay: Available until Nov. 16, 2018; 8558592056 (domestic); +1(404) 5373406 (international); passcode 8164979.
Webcast: Accessible at www.atomera.com
Note about NonGAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a nonGAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, taxes, depreciation, amortization, stockbased compensation, the change in fair value of derivative liabilities, and the gain on the extinguishment of debt. Our definition of adjusted EBITDA may not be comparable to the definitions of similarlytitled measures used by other companies. We believe that this nonGAAP financial measure, viewed in addition to and not in lieu of its reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nanoscaling technologies already in the semiconductor industry roadmap.
Safe Harbor
This press release contains forwardlooking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forwardlooking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations or entered into a definitive royalty-based manufacturing and distribution license agreement with regard to our MST technology, thus subjecting us to all of the risks inherent in a prerevenue enterprise; (2) risks related to our ability to advance the licensing arrangements with our initial integration licensees, Asahi Kasei Microdevices and STM Microelectronics, to royalty-based manufacturing and distribution licenses; (3) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (4) our ability to protect our proprietary technology, trade secrets and knowhow and (5) those other risks disclosed in the section "Risk Factors" included in our Prospectus Supplement Filed with the SEC pursuant to Rule 424(b)(5) on October 11, 2018. We caution readers not to place undue reliance on any forwardlooking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow --
| Atomera Incorporated Condensed Balance Sheets (in thousands, except per share data) | ||||||||
| September 30, | December 31, | |||||||
| 2018 | 2017 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 9,957 | $ | 17,369 | ||||
| Accounts receivable | 75 | 110 | ||||||
| Prepaid expenses and other current assets | 227 | 248 | ||||||
| Total current assets | 10,259 | 17,727 | ||||||
| Property and equipment, net | 63 | 67 | ||||||
| Deferred offering costs | 73 | — | ||||||
| Security deposit | 13 | 13 | ||||||
| Total assets | $ | 10,408 | $ | 17,807 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 354 | $ | 198 | ||||
| Accrued expenses | 319 | 239 | ||||||
| Accrued payroll related expenses | 703 | 512 | ||||||
| Deferred revenue | 75 | — | ||||||
| Total liabilities | 1,451 | 949 | ||||||
| Commitments and contingencies (see Note 8) | ||||||||
| Stockholders' equity: | ||||||||
| Preferred stock, $0.001 par value, authorized 2,500 shares; none issued and outstanding at September 30, 2018 and December 31, 2017 | – | – | ||||||
| Common stock, $0.001 par value, authorized 47,500 shares; 12,409 and 12,161 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively. | 12 | 12 | ||||||
| Additional paid-in capital | 127,708 | 125,911 | ||||||
| Accumulated deficit | (118,763 | ) | (109,065 | ) | ||||
| Total stockholders' equity | 8,957 | 16,858 | ||||||
| Total liabilities and stockholders' equity | $ | 10,408 | $ | 17,807 | ||||
| Atomera Incorporated Condensed Statements of Operations (Unaudited) (in thousands, except per share data) | ||||||||||||||||
| Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||||||
| Revenue | $ | – | $ | – | $ | 96 | $ | – | ||||||||
| Cost of revenue | – | – | (113 | ) | – | |||||||||||
| Gross margin | – | – | (17 | ) | – | |||||||||||
| Operating expenses | ||||||||||||||||
| Research and development | 1,922 | 1,602 | 5,350 | 4,502 | ||||||||||||
| General and administrative | 1,324 | 1,374 | 3,781 | 4,689 | ||||||||||||
| Selling and marketing | 237 | 350 | 695 | 1,367 | ||||||||||||
| Total operating expenses | 3,483 | 3,326 | 9,826 | 10,558 | ||||||||||||
| Loss from operations | (3,483 | ) | (3,326 | ) | (9,843 | ) | (10,558 | ) | ||||||||
| Other income/(expense) | ||||||||||||||||
| Interest income | 48 | 42 | 145 | 106 | ||||||||||||
| Other expense | – | – | – | (6 | ) | |||||||||||
| Total other income/(expense), net | 48 | 42 | 145 | 100 | ||||||||||||
| Net loss | $ | (3,435 | ) | $ | (3,284 | ) | $ | (9,698 | ) | (10,458 | ) | |||||
| Net loss per common share, basic and diluted | $ | (0.28 | ) | $ | (0.28 | ) | $ | (0.80 | ) | $ | (0.90 | ) | ||||
| Weighted average number of common shares outstanding, basic and diluted | 12,117 | 11,862 | 12,079 | 11,684 | ||||||||||||
| Atomera Incorporated Reconciliation to Non- GAAP EBITDA (Unaudited) | ||||||||||||||||||||||||||
| Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||||||||||||||||
| Net loss (GAAP) | $ | (3,435 | ) | $ | (3,284 | ) | $ | $ | (9,698 | ) | $ | (10,458 | ) | |||||||||||||
| Add (subtract) the following items: | ||||||||||||||||||||||||||
| Interest income | (48 | ) | (42 | ) | (145 | ) | (106 | ) | ||||||||||||||||||
| Depreciation and amortization | 8 | 4 | 24 | 13 | ||||||||||||||||||||||
| Stock-based compensation | 630 | 916 | 1,796 | 3,554 | ||||||||||||||||||||||
| Adjusted EBITDA (non-GAAP) | $ | (2,845 | ) | $ | (2,406 | ) | $ | (8,023 | ) | $ | (6,997 | ) | ||||||||||||||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
